04/15/2025
Global Distribution Secured for Neurostimulation Detox Device
Read More
April 15, 2025 — Sunshine Labs, a leading innovator in medical technologies for Substance Use Disorder (SUD), is pleased to announce an exclusive global distribution agreement (excluding the United States) with Sperenza Therapeutics for its flagship device, S.T. Genesis™, with its wholly owned subsidiary, Waxed International. This agreement with Speranza Therapeutics grants Waxed International exclusive … Continued